Skip to main content

Table 3 IPSS scores at baseline, after 4 weeks and after 8 weeks of treatment

From: Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study

 

Baseline

4 weeks

8 weeks

Mean (SD)

Mean (SD)

p

Mean (SD)

p

Total IPSS score

21.6 (3.1)

14.9 (3.6)

< 0.0001

10.9 (2.2)

< 0.0001

IPSS storage sub-score

8.3 (1.8)

6.2 (1.5)

< 0.0001

4.4 (1.0)

< 0.0001

IPSS voiding subs-core

13.2 (2.2)

8.7 (2.4)

< 0.0001

6.5 (1.5)

< 0.0001

IPSS-QoL sub-score

4.6 (0.8)

2.9 (0.8)

< 0.0001

1.5 (0.7)

< 0.0001

  1. IPSS International Prostate Symptom Score, SD Standard Deviation, QoL Quality of Life
  2. with respect to baseline (Paired T Test)